Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA approves Palforzia oral immunotherapy for peanut allergy

Feb. 3, 2020

Kedrion Biopharma completes enrollment in phase III CARES10 study

Jan. 31, 2020

Clover begins development of recombinant subunit vaccine for 2019-nCoV

Jan. 29, 2020

V-4020, a novel VEEV vaccine with increased safety and stability

Jan. 29, 2020

New phase I trial studies monoclonal antibody CIS-43LS against malaria

Jan. 29, 2020

GeoVax and BravoVax sign letter of intent to codevelop 2019-nCoV coronavirus vaccine

Jan. 28, 2020

Protein cereblon inhibitors discovered at Kymera Therapeutics

Jan. 27, 2020

CEPI awards funding to support development of vaccines against coronavirus 2019-nCoV

Jan. 27, 2020

Master clock gene keeps macrophages asleep

Jan. 23, 2020

rVSVN4CT1-EBOVGP1 Ebola virus vaccine demonstrates safety and immunogenicity in phase I study

Jan. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026